A long-term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients.
Katherine J AllnuttSara VogrinJane LiMichelle S Y GohSarah BrennandRachael DavenportAlvin H ChongPublished in: The Australasian journal of dermatology (2022)
Acitretin appears to be well-tolerated and effective in reducing KC in SOTR for at least 5 years. Study limitations include its retrospective nature, small sample size and lack of blinding.
Keyphrases